FOSL2 expression in histologically diagnosed breast cancer: first immunohistochemical evidence from Cameroon. Ananga Noa SA, Dina Bell E, Anaba D, Ndengue CP, et al. BMC Cancer 2026;26:1381.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ananga Noa SA, Dina Bell E, Anaba D, Ndengue CP, et al. FOSL2 expression in histologically diagnosed breast cancer: first immunohistochemical evidence from Cameroon. BMC Cancer 2026;26:1381.
PMID: 43009837